Chengdu Beite Xinqi Biomedical

Chengdu Beite Xinqi Biomedical is the dedicated innovative drug research and development subsidiary of Chengdu Beite Pharmaceutical Group. Based in Chengdu, China, the company focuses on the discovery of novel small molecules and biologics across therapeutic areas such as oncology, metabolic diseases, and anti-infectives. Xinqi operates as a core innovation hub, utilizing advanced drug screening and optimization platforms to advance candidates from early discovery through preclinical development. Its pipeline includes several proprietary programs, such as multi-target agonists for metabolic disorders and targeted small molecules for oncology, aimed at addressing global unmet medical needs. The company is a critical component of its parent group's strategic transition toward an innovation-led biopharmaceutical model.